183 related articles for article (PubMed ID: 27039825)
1. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.
Rogalska A; Sliwinska A; Kasznicki J; Drzewoski J; Marczak A
Asian Pac J Cancer Prev; 2016; 17(3):993-1001. PubMed ID: 27039825
[TBL] [Abstract][Full Text] [Related]
2. Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death.
Sliwinska A; Rogalska A; Marczak A; Kasznicki J; Drzewoski J
Toxicol In Vitro; 2015 Aug; 29(5):1116-23. PubMed ID: 25959860
[TBL] [Abstract][Full Text] [Related]
3. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells.
Rogalska A; Bukowska B; Marczak A
Toxicol In Vitro; 2018 Mar; 47():48-62. PubMed ID: 29117515
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway.
Wang R; Shao X; Yang J; Liu Z; Chew L; Shao Y
J Environ Pathol Toxicol Oncol; 2020; 39(2):179-189. PubMed ID: 32749126
[TBL] [Abstract][Full Text] [Related]
6. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
7. Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells.
Dogan Turacli I; Candar T; Yuksel BE; Demirtas S
Hum Exp Toxicol; 2018 Sep; 37(9):909-919. PubMed ID: 29185360
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
9. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
10. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
11. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.
Yi G; He Z; Zhou X; Xian L; Yuan T; Jia X; Hong J; He L; Liu J
Int J Oncol; 2013 Nov; 43(5):1503-10. PubMed ID: 23982736
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12368-12379. PubMed ID: 33336757
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
[TBL] [Abstract][Full Text] [Related]
17. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
18. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone enhances trichosanthin-induced apoptosis in the HepG2 hepatoma cell line.
Li M; Chen F; Liu CP; Li DM; Li X; Wang C; Li JC
Life Sci; 2010 Jan; 86(1-2):10-6. PubMed ID: 19891978
[TBL] [Abstract][Full Text] [Related]
20. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2.
Ahmadian E; Khosroushahi AY; Eftekhari A; Farajnia S; Babaei H; Eghbal MA
Biomed Pharmacother; 2018 Mar; 99():939-946. PubMed ID: 29710494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
